Owlet (OWLT) Finished Goods (2020 - 2021)

Owlet's (OWLT) quarterly Finished Goods came in at $9.2 million in Q3 2021, up 25.75% on a QoQ basis from $7.3 million in Q4 2020.

Owlet (OWLT) Finished Goods (2020 - 2021) Analysis & Trends

Owlet (OWLT) has 2 years of Finished Goods data on file, last reported at $9.2 million in Q3 2021.

  • On a quarterly basis, Finished Goods changed N/A year-over-year to $9.2 million in Q3 2021; TTM through Sep 2021 was $9.2 million, a N/A change from a year earlier, with the FY2020 full-year figure at $7.3 million, changed N/A from the prior year.
  • Finished Goods for Q3 2021 stood at $9.2 million, up from $7.3 million in the prior quarter.
  • Over the last five years, Finished Goods for OWLT reached as high as $9.2 million in Q3 2021 and fell as low as $7.3 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Owlet 147.80 Mn 106.79 Mn 12.24 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 9.22 Mn
Dec 31, 2020 7.33 Mn